About a month ago, the New England Journal of Medicine told us that they didn’t “have any plans” to retract a paper by Anil Potti. Apparently, they’ve changed their minds.
Today, they posted this retraction notice: Continue reading NEJM retracts Potti paper
Biochemical Journal has retracted two articles by Naoki Mori, bringing the total number of pulled papers by the Japanese cancer researcher to sixteen.
As with the previous Mori retractions, the latest ones — of papers published in 2007 and 2010 — involve unreliable images. Mori, you’ll recall, had recycled control blots from study to study over the years, and was dismissed from his academic post in August.
The 2007 paper, “Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells,” also included a frequent co-author Mariko Tomita, who has been implicated in the deception. It has been cited 15 times, according to Thomson Scientific’s Web of Knowledge. The 2010 article, “Inhibition of Akt/GSK3β signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis,” has not yet been cited.
In each case, the retraction notice is the same: Continue reading Two more retractions for Mori make 16 — but not a record
Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.
Anesthesia & Analgesia has retracted 22 papers by Joachim Boldt, the discredited German anesthesiologist whose prolific career as a researcher has unraveled with stunning rapidity — and 67 more retractions are likely on the way from 10 other titles that have published his work.
The 22 retractions, announced Feb. 25 on the journal’s website, come less than a month after the state medical board overseeing an investigation into Boldt’s publications said that it was looking into more than 90 of his articles out of concern that he had failed to obtain proper approval from an institutional review board for the work.
The board, Landesärztekammer Rheinland-Pfalz (LÄK-RLP), investigated 102 articles. Investigators could not find evidence of adequate IRB approval for 89 papers; for the remaining, 11 had IRB approval and two did not require it, according to the A&A notice, which was signed by editor-in-chief Steven L. Shafer: Continue reading 22 papers by Joachim Boldt retracted, and 67 likely on the way
Another retraction notice for a paper published by Silvia Bulfone-Paus and colleagues has appeared, this one for a 2005 paper in Molecular and Cellular Biology.
The retraction notice is brief but to the point: Continue reading Ninth Bulfone-Paus retraction notice appears, in Molecular and Cellular Biology
We have more news about Jatinder Ahluwalia, whose career has so far been punctuated by dismissal from the University of Cambridge for faking data, and by having been found guilty of scientific misconduct at University College London. Yesterday, we reported that Ahluwalia hadn’t told Imperial College London UCL — where he earned his PhD — about being dismissed from Cambridge.
Today, we learned that Imperial College London, where he he earned his PhD, has also had concerns over Ahluwalia’s work, and is repeating some of his experiments. In a statement, a College spokesperson told Retraction Watch: Continue reading Imperial College London, where Jatinder Ahluwalia did his PhD, now repeating his key experiments
About two weeks ago, we reported that Jatinder Ahluwalia — a scientist at the University of East London (UEL) who had been found guilty of scientific misconduct at University College London (UCL) — had been dismissed from the University of Cambridge’s graduate studies program for data fabrication. A dean at UEL told us later that week that the university was looking into the situation, and the lack of progress and communication from senior officials apparently has the faculty in an uproar. Continue reading Ahluwalia did not tell UCL he had been dismissed from Cambridge
The number of retraction notices of papers co-authored by Silvia Bulfone-Paus is up to eight.
The Journal of Leukocyte Biology, which was apparently the first to announce they had accepted a retraction, has published its notice: Continue reading Two more Bulfone-Paus retraction notices appear
When the American Journal of Respiratory and Critical Care Medicine retracted four publications (two papers, two abstracts) by Edward Erin, who is now sitting in an English jail for having attempted to poison his mistress to induce an abortion, it appeared that the damage to the medical literature might be far worse. Erin’s name had appeared on many more publications, including five articles published in Clinical & Experimental Allergy (CEA) since 2002.
Prompted by an inquiry from Retraction Watch, CEA conducted an investigation into its Erin publications, reaching out to his co-authors. Today we received an e-mail from Andrew Wardlaw, editor of CEA, informing us of a letter that will appear in an upcoming issue of the journal: Continue reading Allergy journal clears studies linked to jailed U.K. researcher Erin
On Friday, we reported that the University of East London (UEL) was looking into the career of Jatinder Ahluwalia, the UEL researcher who has left a trail of alleged scientific misconduct at Cambridge University and University College London.
Today, in another Retraction Watch exclusive, we have obtained a letter sent by a faculty member at UEL to department colleagues. It suggests that faculty there are very concerned about the toll these allegations may take on the university’s students and reputation, and are furious that senior officials have failed to keep them in the loop about any potential investigation.
Here’s the text of the letter: Continue reading Exclusive: UEL staff “in uproar about lack of progress” investigating Jatinder Ahluwalia
Another retraction notice for a paper by Silvia Bulfone-Paus and colleagues has appeared, this one for a 2007 paper in the Journal of Biological Chemistry (JBC), “Soluble IL-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with Il-15.”
This is the sixth retraction notice of a promised 12 in several journals. The original paper has been cited 37 times, according to Thomson Scientific’s Web of Knowledge.
Some of the notices have gone into great detail about what was wrong with the original papers, and journals have even allowed the team to declare that some of the results had been replicated. One simply said there had been misconduct.
Then there’s this one: Continue reading Bulfone-Paus retraction notice appears in the Journal of Biological Chemistry